| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.63 | 0.02 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |